GDC-0941 dimethanesulfonate - CAS# 957054-33-0 Catalog No.:M10946-2 InChi: InChI=1S/C23H26N2O2S/c1-3-18-9-11-20(12-10-18)23-25-21(17(2)27-23)15-28-16-22(26)24-14-13-19-7-5-4-6-8-19/h4-12H

InChi: InChI=1S/C23H26N2O2S/c1-3-18-9-11-20(12-10-18)23-25-21(17(2)27-23)15-28-16-22(26)24-14-13-19-7-5-4-6-8-19/h4-12H

BRN0123183

Solubility: DMSO: 100 mg/mL(136

Approximately 75% more tumor cells exhibited apoptotic changes in the 100 mg/kg treatment group compared with vehicle control group at 8 h after dosing

Georgiadou M

GDC-0941 dimethanesulfonate - CAS# 957054-33-0 Catalog No.:M10946-2 InChi: InChI=1S/C23H26N2O2S/c1-3-18-9-11-20(12-10-18)23-25-21(17(2)27-23)15-28-16-22(26)24-14-13-19-7-5-4-6-8-19/h4-12HPictilisib, also known as Pictrelisib, GDC 0941, RG7321 and GNE0941 , is an orally bioavailable, and is a potent small molecule thieno[3,2 d]pyrimidine inhibitor of the class I phosphatidylinositol 3 kinase (PI3K) isoforms p100alpha and p100delta with potential antineoplastic activity. GDC 0941 selectively binds to PI3K isoforms in an ATP competitive manner, inhibiting the production of the secondary messenger phosphatidylinositol 3,4,5 trisphosphate